Seong J. Park

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Field direction of static magnetic fields influences kidney fibrosis progression through MAPK signaling and cell cycle alteration.

Field direction of static magnetic fields influences kidney fibrosis progression through MAPK signaling and cell cycle alteration.

Journal: Scientific reports

Published: April 07, 2025

Effects of Graphene Quantum Dots on Renal Fibrosis Through Alleviating Oxidative Stress and Restoring Mitochondrial Membrane Potential.

Effects of Graphene Quantum Dots on Renal Fibrosis Through Alleviating Oxidative Stress and Restoring Mitochondrial Membrane Potential.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 05, 2024

Soluble ST2 is an early marker and treatment target for hypertensive nephrosclerosis signatured in glomerular mesangial cells.

Soluble ST2 is an early marker and treatment target for hypertensive nephrosclerosis signatured in glomerular mesangial cells.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: April 04, 2024

STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation.

STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation.

Journal: Cell communication and signaling : CCS

Published: March 16, 2024

Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.

Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.

Journal: British journal of cancer

Published: October 03, 2016

Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.

Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.

Journal: Oncotarget

Published: July 20, 2016

SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.

SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 04, 2015

First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.

First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.

Journal: Investigational new drugs

Published: April 12, 2015

Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.

Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.

Journal: Annals of surgical oncology

Published: April 02, 2015

Imaging Features of Primary Tumors and Metastatic Patterns of the Extraskeletal Ewing Sarcoma Family of Tumors in Adults: A 17-Year Experience at a Single Institution.

Imaging Features of Primary Tumors and Metastatic Patterns of the Extraskeletal Ewing Sarcoma Family of Tumors in Adults: A 17-Year Experience at a Single Institution.

Journal: Korean journal of radiology

Published: January 03, 2015

Predicting the efficacy of an oral paclitaxel formulation (DHP107) through modeling and simulation.

Predicting the efficacy of an oral paclitaxel formulation (DHP107) through modeling and simulation.

Journal: Clinical therapeutics

Published: October 14, 2014

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Journal: The Lancet. Oncology

Published: September 10, 2014

Showing 1-12 of 21

Last Updated: 09/26/2026